REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $906,749 | +14.9% | 75,062 | +0.7% | 0.00% | – |
| Q2 2023 | $788,866 | +6.7% | 74,562 | -0.7% | 0.00% | – |
| Q1 2023 | $739,004 | -33.1% | 75,102 | 0.0% | 0.00% | – |
| Q4 2022 | $1,104,751 | +23.4% | 75,102 | +1.7% | 0.00% | – |
| Q3 2022 | $895,000 | -12.6% | 73,842 | +0.8% | 0.00% | – |
| Q2 2022 | $1,024,000 | +11.5% | 73,242 | +13.6% | 0.00% | – |
| Q1 2022 | $918,000 | -32.1% | 64,469 | +0.6% | 0.00% | – |
| Q4 2021 | $1,351,000 | +46.8% | 64,109 | +82.9% | 0.00% | – |
| Q3 2021 | $920,000 | -12.6% | 35,044 | +3.8% | 0.00% | – |
| Q2 2021 | $1,053,000 | +1.2% | 33,774 | -0.4% | 0.00% | – |
| Q1 2021 | $1,041,000 | -3.3% | 33,908 | +7.9% | 0.00% | – |
| Q4 2020 | $1,077,000 | – | 31,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |